Hexagon Nutrition Board Approves Q1 FY27 Results, Recommends 30 Paise Dividend
Hexagon Nutrition approved Q1 FY27 results and recommended a final dividend of 30 paise per share for FY26. The AGM is scheduled for September 22, 2026. Key management remuneration revisions and appointments were also approved.
The approval of quarterly results, dividend recommendation, and key management appointments are material events for shareholders and stakeholders, impacting the company's governance and financial outlook.
The announcement reports on routine financial results, dividend recommendation, and board appointments, which are standard corporate actions. While the dividend is a positive step, the financial results themselves do not show significant positive or negative movement that would sway the sentiment.
Hexagon Nutrition Limited's Board of Directors met on August 12, 2026, and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also recommended a final dividend of 30 paise per equity share for the financial year ended March 31, 2026. The 33rd Annual General Meeting (AGM) is scheduled for September 22, 2026, conducted via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The book closure for the AGM will be from September 16, 2026, to September 22, 2026. The record date for determining eligibility for the final dividend is September 15, 2026. Additionally, the board approved revisions in annual remuneration for Chairman and Executive Director Mr. Arun Purushottam Kelkar, Managing Director Mr. Vikram Arun Kelkar, and Joint Managing Director Dr. Nikhil Arun Kelkar, subject to member approval. Mr. Arun Purushottam Kelkar's re-appointment as Chairman & Director was also recommended. Mr. Raghunath Sawant was appointed as an Additional Executive Director effective August 12, 2026. The Articles of Association will be altered, subject to member approval. The IPO Committee has been dissolved following the successful completion of the IPO. The trading window for the company shares will open 48 hours after the declaration of the financial results for the quarter ended June 30, 2026.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.